Table 4.
Patient group | Coefficient (SE) | P value | Sample size |
All samples, adjusted for concomitant DMARD | −0.07 (0.02) | 5e−05 | 2922 |
All samples, no adjustment for DMARD | −0.08 (0.02) | 2e−05 | 2922 |
Samples not on concomitant DMARD | −0.02 (0.04) | 0.5 | 691 |
Samples on concomitant DMARD | −0.09 (0.02) | 1e−05 | 2231 |
Samples on concomitant MTX | −0.1 (0.03) | 0.002 | 958 |
The coefficients are the effect sizes of the standardised score on the standardised phenotype. The phenotype is adjusted for covariates: baseline DAS components, gender, cohort, genotyping array, 10 genetic principal components.
DAS, Disease Activity Score; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; SJC, swollen joint count.